We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Clinical and diagnostic values of metagenomic next-generation sequencing for infection in hematology patients: a systematic review and meta-analysis
Summary
Researchers conducted a systematic review and meta-analysis showing that metagenomic next-generation sequencing (mNGS) — a technology that identifies pathogens by reading their DNA — achieves high detection rates for infections in blood cancer patients. The findings suggest mNGS can guide antibiotic decisions and improve patient outcomes, particularly in China where the evidence base is strongest.
mNGS has high positive detection rates in hematology patients. mNGS can guide clinical antibiotic adjustments and improve prognosis, especially in China.
Sign in to start a discussion.